Results

Total Results: 2,647 records

Showing results for "treatment".

  1. effectivehealthcare.ahrq.gov/sites/default/files/pdf/restless-legs_research-protocol.pdf
    December 16, 2011 - therapy, can occur during the first 2 years of treatment and sometimes many years into treatment. … ; 1 = very good, 4 = unchanged or worsened)  Side-effects (item 4; 1 = none, 4 = outweighs therapeutic … What are the benefits from RLS treatments when compared to placebo or no treatment? b. … What are the harms from RLS treatments when compared to placebo or no treatment? b. … Comparators  Placebo (or sham treatments), no treatment, or other active comparator Outcomes
  2. effectivehealthcare.ahrq.gov/sites/default/files/pdf/ear-infection_research-protocol.pdf
    August 07, 2012 - Nonpharmacological Interventions Autoinflation of the Eustachian tube Complementary and alternative therapiesTreatments and Treatment Strategies That Will Be Addressed in This Review: Rationale for inclusion … Comparators included no treatment, watchful waiting, and other established treatments. … KQ 1: What is the comparative effectiveness of the following treatment options (active treatments and … Treatments That Will Not Be Addressed in This Review: Rationale for Exclusion Treatments and Treatment
  3. #05 DEPRESSION (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/depression-horizon-scan-high-impact-1506.pdf
    June 01, 2015 - , screening and diagnostics, therapeutics, surgery, programs, and care delivery innovations that address … for patients whose conditions fail to respond to available medications and behavioral therapies for … Personalized drug therapy has traditionally lagged behind behavioral therapy in this regard because … Double-blind, placebo-controlled trial of ketamine therapy in treatment-resistant depression (TRD … Therapeutic options in treatment-resistant depression. Ann Med. 2011 Nov;43(7):512-30.
  4. #05 DEPRESSION (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/05_depression_potential_high_impact_2012-12-10.pdf
    January 01, 2012 - Overall high-impact potential: deep brain stimulation (Reclaim DBS Therapy or Libra DBS) for treatment-resistant … and psychotherapy as first- and second-line therapies and electroconvulsive therapy or repetitive … treatments for treatment-resistant MDD, investigators have sought new approaches because available … DBS therapy is incompatible with some other device-based depression treatments. … Overall high-impact potential: deep brain stimulation (Reclaim DBS Therapy or Libra DBS) for treatment-resistant
  5. effectivehealthcare.ahrq.gov/sites/default/files/suppl-2-user-guide-to-ocer_130129.pdf
    January 01, 2011 - primary goal of nonexperimental comparative effectiveness research is to compare the effect of study treatments … studies, marginal exchangeability can rarely be assumed, since patients and providers typically select treatments … To simplify, consider a randomized trial of antihypertensive treatments (CCB or other) and the outcome … alcohol abuser but remained in the study suggests that she did not experience adverse effects of therapyTreatment (A) is randomized.
  6. effectivehealthcare.ahrq.gov/sites/default/files/ch_10-user-guide-to-ocer_130129.pdf
    January 01, 2011 - Consider, for example, HIV patients who may be treated with antiretroviral therapy. … The use of antiretroviral therapy may change over time and decisions about therapy may in part be based … In the HIV example, CD4 count may be affected by prior therapy decisions, but CD4 count levels may … themselves go on to alter subsequent therapy decisions and the final survival outcome. … A difficulty arises in that CD4 count is both a confounding variable (for subsequent therapy and final
  7. effectivehealthcare.ahrq.gov/sites/default/files/pdf/horizon-scan_research-2015.pdf
    January 01, 2015 - , screening and diagnostics, therapeutics, surgery, programs, and care delivery innovations that address … recently and will be used in place of existing treatments in some patients and as an addition to treatment … Although cost information is not yet available, oral microbiome-based therapeutics (i.e., capsules) … Hypertension Therapeutic device $1,000,000,000 $500,000,000 Lomitapide (Juxtapid) for Treatment … Competition could eventually lower the price of of these treatments.
  8. effectivehealthcare.ahrq.gov/sites/default/files/related_files/kidney-stone-prevention_executive.pdf
    March 01, 2013 - laboratory results is associated with better clinical health outcomes than empiric therapy. … In adults with a history of nephrolithiasis, what is the evidence that pharmacological therapies to … with placebo, usual care/no treatment, or other available active treatments. … when added to this diet therapy. … Few trials directly compared active pharmacological treatments.
  9. effectivehealthcare.ahrq.gov/sites/default/files/pdf/depression-treatment-ssri_research-protocol.pdf
    June 15, 2010 - • Comparators: CPG may not provide recommendations on comparator treatments. … Depression Treatment after Unsatisfactory Response to SSRIs when used as First-line Therapy  … Medicine (e.g., Biofields therapies (Reiki, Qi Gong) and bioelectromagnetic based therapies) e) Biologically … The search strategy was not delimited by treatments or outcomes. … per week, number of total treatments, treatment fidelity for psychotherapy), treatment duration (total
  10. effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0108_05-24-2009.pdf
    January 01, 2009 - Completion Date: 1-12-10 1 Results of Topic Selection Process & Next Steps  Acute migraine treatment … IV Benadryl, Toradol, and Reglan in an emergency department or clinical setting for acute migraine treatment … has been effective in treating migraines in patients and would like to see evidence supporting this treatment …  There appears to be significant clinical uncertainty surrounding acute migraine treatment in …  A review specifically focused on the treatment combination posed by the nominator would not be
  11. #05 DEPRESSION (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/depression-horizon-scan-high-impact-1406.pdf
    June 01, 2014 - , screening and diagnostics, therapeutics, surgery, programs, and care delivery innovations that address … cognitive behavior therapies. … efficacy for suicidal ideation and as an adjunct treatment to behavior and brain-stimulation therapies … added to existing therapies. … Therapeutic options in treatment-resistant depression. Ann Med. 2011 Nov;43(7):512-30.
  12. effectivehealthcare.ahrq.gov/sites/default/files/related_files/suicidal-thoughts-young-people-exe-sum.pdf
    April 01, 2025 - No eligible study evaluated neurotherapeutics therapies. … factors common to all psychotherapeutic approaches and supportive treatments, such as empathy, therapeutic … Control treatments across most comparison studies mostly involved treatment as usual, which consisted … These treatments were often matched to the intervention treatment in format (e.g. group and individual … A comparative study of mode deactivation therapy (MDT) as an effective treatment of adolescents with
  13. Layout 1 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/prostate-cancer_executive.pdf
    February 01, 2008 - Even if differences in therapeutic effectiveness exist, differences in adverse effects, convenience, … It is not known whether these therapies are better or worse than other treatments for localized prostate … The absolute risk of impotence and treatment-related morbidity appeared to be similar to other treatments … radiation therapy vs. other treatments. 1 systematic review of nonrandomized studies found no direct … • The most commonly reported patient characteristics used as stratifying factors for therapeutic outcomes
  14. 04-E029-1 Summary (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/prostate-cancer-surveillance_executive.pdf
    December 01, 2011 - therapy (ADT), are offered with curative intent. … with or without androgen deprivation therapy (ADT). … Observational Management Strategies Versus Combined Active Treatments or Combined Radiation Treatment … EBRT and BT (combination therapy) had a higher rate of receiving treatments for urethral stricture compared … grouping treatments or selectively excluding treatments.
  15. effectivehealthcare.ahrq.gov/sites/default/files/pdf/hepatitis-c_research-protocol.pdf
    November 30, 2011 - , and adherence to HCV antiviral therapy. … with the level of detail suggested by the key informants, including the comparative effectiveness of treatments … Input from Key Informants: Review of Hepatitis C Treatments During the topic refinement process, … Question 2 What is the comparative effectiveness of antiviral treatments on intermediate outcomes … is not applicable to those who failed previous therapies or are nonresponders.
  16. effectivehealthcare.ahrq.gov/sites/default/files/08_functional_limitations_potential_high_impact_2012-12-10.pdf
    January 01, 2012 - uncontrolled by other therapeutic agents. … would be very accepting of this therapy because of the lack of other effective treatments, marking … patients an effective therapy option within the current treatment model. … Edison (NJ): Oceana Therapeutics, Inc.; 2010 Dec 2. 65 p. 48. … Oceana Therapeutics announces U.S. launch of Solesta, the only nonsurgical FDA approved treatment
  17. PEPTIC ULCER #11 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/peptic-ulcer-horizon-scan-high-impact-1506.pdf
    June 01, 2015 - , screening and diagnostics, therapeutics, surgery, programs, and care delivery innovations that address … with one or more standard therapies, including corticosteroids, immunomodulators, or tumor necrosis … unmet need for new therapeutic options for patients with IBS. … , alternative therapies are needed. … FDA approves two therapies to treat IBS-D. [internet]. Silver Spring (MD): U.S.
  18. effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0359_10-15-2010.pdf
    January 01, 2010 - Patients with multiple sclerosis or clinically isolated syndrome Intervention(s): Disease-modifying therapies … for delay of relapse and disability, treatments to address symptoms of multiple sclerosis, including … pharmaceutical and non-pharmaceutical treatments Comparator(s): Comparative effectiveness of disease-modifying … therapies, comparative Diagnosis and Treatment of Multiple Sclerosis Nomination Summary Document … There is no cure for MS; treatments aim to reduce the frequency and hasten recovery from relapses and
  19. Title (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/pdf/mental-illness-adults-prisons_research-protocol.pdf
    September 13, 2012 - , or dialectical therapy) X X X X Psychopharmacologic therapies (includes, first-generation antipsychotics … (ACT/FACT) X Modified therapeutic community X X X Other treatments (e.g., art therapy, music … Drug therapy/ Exp antidepressive agents/ Psychotropic drugs/ Therapeutic use.fs. … / OR exp psychotherapy/ OR cognitive therapy/ OR exp complementary therapies/ OR counseling/ OR exp … OR cognitive therapy OR (cognitive ADJ behav* ADJ (therapy OR treatment)) OR CBT OR (community based
  20. Layout 1 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/sleep-apnea_executive.pdf
    July 01, 2011 - all patients, since such decisions should be individualized. 11 The second alternative to CPAP therapeutic … were potentially Treatment transient and could be alleviated with either stopping treatment OSA treatmentsTreatment • By meta-analysis, MAD results in a statistically significant OSA treatments reduction in … to sham surgery, conservative therapy, or no treatment. … Treatments to improve • A single study evaluated the effect of cognitive behavioral compliance therapy

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: